Abbi E. Smith
Impact in
-
- Neurofibromatosis and Schwannoma Cases
- Neuroblastoma Research and Treatments
Papers in
- Neurology 12
- Neurofibromatosis and Schwannoma Cases 12
- Neuroblastoma Research and Treatments 3
-
- Epigenetics and DNA Methylation 1
- Ubiquitin and proteasome pathways 1
- Co-authors
- Waylan Bessler (10 shared papers)Steven D. Rhodes (9 shared papers)D. Wade Clapp (10 shared papers)Xiaohong Li (3 shared papers)Julie A. Mund (3 shared papers)Adam R. Smith (1 shared paper)George E. Sandusky (6 shared papers)Sara Sigurbjörnsdóttir (1 shared paper)
- Journals
- Human Molecular Genetics (2 papers)Molecular Cancer Therapeutics (1 paper)Neuro-Oncology Advances (1 paper)Oncotarget (1 paper)American Journal of Health-System Pharmacy (1 paper)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Abbi E. Smith
15 papers receiving 167 citations
Peers
Comparison fields: 5 of 56
- Neurology 76
- Rheumatology 20
- Cell Biology 18
- Cellular and Molecular Neuroscience 19
- Pulmonary and Respiratory Medicine 28
Countries citing papers authored by Abbi E. Smith
This map shows the geographic impact of Abbi E. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abbi E. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abbi E. Smith more than expected).
Fields of papers citing papers by Abbi E. Smith
This network shows the impact of papers produced by Abbi E. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abbi E. Smith. The network helps show where Abbi E. Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Abbi E. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 57 | |
| 2 | 2010 | 33 | |
| 3 | 2022 | 19 | |
| 4 | 2021 | 14 | |
| 5 | 2021 | 12 | |
| 6 | 2019 | 10 | |
| 7 | 2020 | 6 | |
| 8 | 2017 | 6 | |
| 9 | 2021 | 3 | |
| 10 | Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of Nf1-Deficient Mice | 2019 | 2 |
| 11 | 2021 | 2 | |
| 12 | Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation | 2019 | 1 |
| 13 | 2020 | 1 | |
| 14 | 2025 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2018 | 0 |
About Abbi E. Smith
Abbi E. Smith is a scholar working on Neurology, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Epidemiology, having authored 16 papers that have together received 168 indexed citations. Recurring topics across this work include Neurofibromatosis and Schwannoma Cases (12 papers), Sarcoma Diagnosis and Treatment (3 papers), Peptidase Inhibition and Analysis (3 papers), Neuroblastoma Research and Treatments (3 papers), Meningioma and schwannoma management (2 papers), Genetics and Neurodevelopmental Disorders (1 paper), Epigenetics and DNA Methylation (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Neurology (76 citations), Rheumatology (20 citations), Cell Biology (18 citations), Cellular and Molecular Neuroscience (19 citations) and Pulmonary and Respiratory Medicine (28 citations). Abbi E. Smith has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Waylan Bessler, Steven D. Rhodes, D. Wade Clapp, Xiaohong Li, Julie A. Mund, Adam R. Smith, George E. Sandusky, Sara Sigurbjörnsdóttir, Christopher M. Hofmann and N. Justin Marshall. Their work appears in journals such as Human Molecular Genetics, Molecular Cancer Therapeutics, Neuro-Oncology Advances, Oncotarget and American Journal of Health-System Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.